ArticleExperimental & molecular medicine2026

DNA methyltransferase inhibition is a therapeutic vulnerability in VHL-deficient renal cell carcinoma cells.

Yue Pu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.